Do Vaccines Protect Against Long Covid?

As the epidemic enters its third year, the long-running disease has emerged as a major concern. And many are wondering if taking a code shot can reduce their chances of developing long-term symptoms.

The jury is still out, but a growing number of studies suggest that the vaccine may reduce the risk of long-term symptoms – although it cannot be eliminated.

The UK’s Health Security Agency Analysis Of the eight studies that were published on the subject before mid-January. It found that six studies had shown that people who had been vaccinated with the coronavirus were less likely to develop symptoms of chronic coccidiosis than those who had not been vaccinated. The other two studies have shown that vaccination does not appear to reduce the chances of long-term growth of cod.

The results of some studies suggest considerable protection, while others benefit only slightly.

One Great study The US Veterans Health Administration’s electronic records of patients showed that patients who were vaccinated with covid had a 13 per cent lower risk of developing symptoms six months later than those patients.

Two studies in the UK have had a major impact. One the study Of the approximately 1.2 million people, vaccinated patients had a 50% lower risk of chronic symptoms, based on patient reports via a phone app. one more which was not peer-reviewed and was based on a survey of approximately 6,000 patients, found a 41% lower risk.

O the study With the collaboration of healthcare data firm, Arcadia, and government and healthcare leaders in the private sector, American patients in the Code Patient Recovery Alliance continue to benefit greatly. The study, which was not peer-reviewed, analyzed the records of approximately 240,000 patients infected with the coronavirus by May 2021 and found that those who received a dose of the covid vaccine before infection. A lone coyote is onisseventh to one-tenth as likely to report two or more symptoms after 12 to 20 weeks. The study also found that people who received their first dose of the vaccine after contracting the coronavirus were less likely to develop long-term cod than those who had not been vaccinated, and as much. The sooner they are vaccinated after infection, the lower the risk of long-term symptoms.

The survey found that those who received two doses of the vaccine had a lower risk of between 54% and 82% of patients receiving the 10 most common long-term symptoms. Seven of them report being in. The study said they were less likely to report symptoms such as headaches, muscle aches and other problems than the general population, the study said. (The authors stated that they could not confirm whether the patients had been vaccinated before or after receiving the vaccine, but said that due to Israel’s vaccination policy it is possible that most people who are vaccinated) Shortly after transplantation, two doses of coronavirus were found.

Researchers compared about 48,000 patients who had not been vaccinated after being vaccinated against coccidiosis when they were vaccinated with about 16,000 patients, which has not yet been published. He found that vaccinated patients often benefited from a reduced risk of lung problems and blood clotting problems, said the author, a doctor. Ziad Ali, Head of Research and Development at VA Senate. Lewis Healthcare System and a medical epidemiologist at the University of Washington in St. Louis. Lewis said other symptoms showed a “very low risk” from the vaccine.

“The overall message is that vaccines reduce but do not eliminate the risk of long-term colic,” the doctor said. Al-Ali added: “Reliance on vaccination as a single mitigation strategy is completely inadequate. It is tantamount to fighting a shield that only works partially.

An analysis Regarding the electronic medical records of patients in the United States, researchers in the UK compared about 10,000 people who had received the cod vaccine to the same number of people who had not been vaccinated against the coronavirus but had the flu. The vaccine was found. The number of people in the study who may have been reluctant to be vaccinated or who generally had less healthy behaviours.

Research has shown that vaccinating against the coronavirus before being infected did not reduce the risk of most symptoms of chronic colic. The authors wrote that the data suggest that vaccinators may be at lower risk of long-term symptoms such as abnormal breathing and cognitive problems, the authors wrote, but the results were not statistically conclusive. ۔

The researchers said that it is possible that because their data was released on electronic health records, the study only caught patients with very severe symptoms, rather than a wide range of patients who did not seek medical help for their symptoms.

One reason is the difference in self-study. Not all researchers have defined the long cove in the same way, measured the same symptoms or tracked patients at the same time. For example, some studies recorded symptoms that persisted for at least 28 days after infection, while others measured the symptoms that people were experiencing six months later. Studies that rely on patient surveys can yield very different results from those based on electronic medical records. And some studies did not have very diverse populations. For example, in the study of veterans, the patients were mostly old, white and male.

Most published statistics follow patients infected early in the epidemic. Some recently published figures include people infected with the highly contagious Delta variant, but it is too early to read about vaccines and long cords, including the Omicron variant. It is also too early for studies examining the effect of boosters on long coils.

Yes. Vaccines are very effective in preventing people from becoming seriously ill with infections, of which all types are still known. And many studies have shown that cove patients are ill enough to be hospitalized and are more likely to have chronic health problems. Therefore, by keeping people out of the hospital, the vaccine should reduce the chances of this type of long-term postcode case.

Nevertheless, many people with chronic conidia had mild or even asymptomatic early infections, and while some studies have shown that vaccines have the potential to reduce their long-term symptoms, the evidence is not conclusive. Are

Vaccines provide some protection against infection – and avoiding infection is certainly the surest way to prevent long-term colic.

So far, studies have not found that different vaccines have different effects on long-term symptoms.

Scientists say the cause of the long cold is still unclear, and different patients may have different underlying causes of different symptoms. Some have suggested that the condition may be related to the virus’s genetic makeup after the initial infection has subsided. Another theory is that persistent problems are related to inflammation or circulatory problems caused by a more active immune response that is unable to stop.

Akiko Iwasaki, an immunologist at Yale, says the vaccine may be able to provide long-term relief to people whose symptoms are caused by the virus if the vaccine-derived antibodies remove the residue.

But in people whose symptoms may be due to a post-viral reaction similar to an autoimmune disease, he said, vaccines can only help temporarily, and problems such as fatigue may recur.

When vaccinated for the first time, some patients with long-term covidosis have found that symptoms such as cerebral palsy, joint pain, shortness of breath, and fatigue have improved after vaccination. However, many people did not notice any difference in their symptoms after vaccination, and a small percentage said they felt worse.

In a study by the  Office for National Statistics In the UK, it was found that in people aged 18 to 69 who reported their symptoms between February and September 2021, the first dose of the vaccine reduced the chances of reporting long-term symptoms by 13%. A second dose further reduced complications by 9%, the study found.